Zoom in

For every person suffering from cancer, being aware of the existence of a treatment that provides the opportunity to feel physically and mentally better, prolongs relapse free periods and even has positive impact in terms of survival, means finding a new opening for relief and hope.

That is the reason why so many oncologic patients in Cuba and the world presently thank its biotechnological industry, as well as its specialists for the recent development of therapeutic vaccines and monoclonal antibodies that have become a silver lining for people fighting this evasive disease, which does not respect ages or latitudes.
Listening to Mick Phillips from the U.S., for example, who has spent five years traveling to the Caribbean island for follow-up consultations at La Pradera International Healthcare Center and secretly take new doses of CIMAVAX EGF® back to his country, was the best way to confirm that human beings are capable of going beyond any obstacle in the fight to stay alive.
Both CIMAVAX EGF® and Racotumumab, labeled as vaccines based on the immunotherapy principle that targets lung tumors featuring advanced cells, are some of the modern treatment alternatives. They succeed as part of a comprehensive oncology program that has been developed by Cuba over the past years.
Guided by the National Oncology and Radiobiology Institute (INOR is the Spanish acronym), and backed up by several medical and research entities, that program also fights cancer by providing wellness and quality of life for people that will give them special value.

Mick Phillips: One Voice among Many

Numerous reports have been aired over the past years, with testimonies given by patients from every corner of earth, who have come to Cuba to get their lung cancer treated, in phases when radiation and chemotherapy do not assure more than some months without having a relapse. U.S. patients are to be highlighted in this group, since they have no other choice but to break the embargo law and travel to Havana looking for hope.
“I’d be dead for sure without this medicine,” 69-year-old Mick Phillips told the press back in 2017, since he had been diagnosed with this terrible disease over five years ago. His survival testimony “thanks to CIMAVAX vaccine” has been widely spread.
It is important to mention that Mr. Phillips’ doctor, oncologist Timothy Goggins, from Appleton, Wisconsin, also recognized that this treatment had helped in terms of the remission of this cancer. “I’ve seen patients that respond to chemotherapy and feel well for some time, but most of them suffer a relapse, generally within a short period. Living five years with this is pretty amazing,” the specialist said.
These and many other similar statements have fostered the growing interest of several experts and researchers from the U.S. medical industry in studying the immunotherapy alternatives developed in Cuba.